Pressroom: Media Coverage

Showing 281 - 300 of 555 news items


Genome Sequencing Clears Up a Cancer Medical Mystery

Cancer researcher and Human Oncology and Pathogenesis Program member David Solit spoke about a study he led that sequenced the entire genome of a patient whose cancer disappeared when she took an experimental drug that didn’t help others.

August 23, 2012
Child Cancer Patients at Greater Risk of Diabetes, Study Shows

Directors of Memorial Sloan Kettering’s long-term follow-up programs Kevin Oeffinger and Charles Sklar authored a commentary on a study that found that cancer patients who underwent radiation therapy as children are at greater risk of developing diabetes later in life.

August 22, 2012
Watson Turns Medic: Supercomputer to Diagnose Disease

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on Memorial Sloan Kettering’s collaboration with IBM to develop a decision-support tool based upon the IBM Watson system.

August 22, 2012
Jewish Men in Middle of PSA Controversy

Prostate cancer surgeon James Eastham spoke about screening men for prostate cancer. BRCA gene mutations, which are ten times more common in Ashkenazi Jews, can increase the risk for breast, ovarian, and prostate cancers.

August 17, 2012
Experimental Pill Adds Months to Lives of Prostate Cancer Patients

Medical oncologist Howard Scher discussed a study he led that found that a novel drug extended the lives of men with advanced prostate cancer.

August 15, 2012
Amgen, Citing Weak Results, Halts Study of a Cancer Drug

Medical oncologist Leonard Saltz commented on a late-stage clinical trial of an experimental drug for pancreatic cancer that was halted after an outside monitoring panel concluded that the drug was unlikely to improve the survival of patients with an advanced form of the disease.

August 10, 2012
The Latest Mammogram Controversy: Density

Radiologist Carol Lee commented on a new law that requires doctors to inform women with dense breast tissue that this makes detecting breast cancer more difficult and may be associated with an increased risk of cancer.

August 7, 2012
Cancer May Result from Wrong Number of Genes

Medical oncologist and geneticist Zsofia Stadler discussed a study she led that found that some early-onset testicular cancers may result from spontaneous, or de novo, genetic changes. These de novo mutations are not inherited from either parent, but arise in either the egg or sperm cell or sometime during embryonic development.

August 2, 2012
Life, Interrupted: The First 100 Days

Memorial Sloan Kettering patient Suleika Jaouad spoke about reaching her 100th day after her bone marrow transplant.

July 27, 2012
Eat Antioxidants to Lower Pancreatic Cancer Risk?

Herbalist Simon Yeung commented on a study that suggested that diets rich in antioxidants may help lower the risk of developing pancreatic cancer.

July 24, 2012
Nurses and Physicians Collaborate to Improve Cancer Care

Medical oncologist Dean Bajorin discussed the collaboration between advanced practice nurses and oncologists in the treatment of cancer patients.

July 24, 2012
Law Aims to Boost Breast Cancer Detection

Radiologist David Dershaw commented on a new law that requires doctors to inform women with dense breast tissue that this makes detecting breast cancer more difficult and may be associated with an increased risk of cancer.

July 24, 2012
Indoor Tanning Bans More Common Than a Decade Ago

Dermatologist Steven Wang discussed a study that found that more and more countries and US states are banning indoor tanning or restricting access to it.

July 19, 2012
Sloan Kettering's Powerful MRI in the Operating Room Helped Save the Life of Upper East Side Mother of Three

Neurosurgeon Philip Gutin used a powerful MRI machine to help him remove an aggressive brain tumor in Memorial Sloan Kettering patient Barbara Basser Bigio.

July 17, 2012
Memorial Sloan Kettering Ranked No. 2 Cancer Hospital by U.S. News & World Report

Memorial Sloan Kettering was ranked the No. 2 hospital for cancer care in U.S. News & World Report’s 2012–13 Best Hospitals issue.

July 17, 2012
Cancer Doctors Say Broach PSA Test with Some Men

An American Society of Clinical Oncology (ASCO) panel, co-chaired by medical oncologist Ethan Basch, released recommendations on prostate cancer screening that said that doctors should discuss the pros and cons of screening with men who have a life expectancy of more than ten years, and discourage PSA testing for men with a shorter life expectancy.

July 16, 2012
Drug Raises Hope for Better Bone Marrow Transplant Recovery

Hematologic Oncology Division Head Marcel van den Brink commented on a study that found that an existing drug for HIV helps prevent graft-versus-host disease, the most serious complication of bone marrow transplants.

July 12, 2012
A Meeting of Minds: Young Oncologists Make the Most of the ASCO Annual Meeting

Memorial Sloan Kettering fellows Ayca Gucalp and James Harding spoke about their experience at the American Society of Clinical Oncology’s Annual Meeting, the nation’s largest conference for oncologists.

July 10, 2012